Disproportionality analysis of reslizumab based on the FDA Adverse Event Reporting System
Therapeutic Advances in Drug SafetyBackground: With the increasing prescription of reslizumab for severe asthma with an eosinophilic phenotype, a real-world pharmacovigilance analysis of reslizumab is urgently required to detect potential unreported adverse events (AEs) in clinical ...
Huqun Li, Cuilian Guo, Chongshu Wang
doaj +1 more source
Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women [PDF]
, 2014 Pedro L. Moro +4 more
openalex +1 more source
Advanced Engineering Materials, EarlyView.This perspective article explores an innovative powder metallurgical approach to producing high‐nitrogen steels by utilizing a mixture of stainless steel and Si3N4. This mixture undergoes hot isostatic pressing followed by direct quenching. The article also examines adapting this method to laser powder bed fusion (PBF‐LB/M) to overcome nitrogen ...
Louis Becker +5 more
wiley +1 more source
Post-Marketing Pharmacovigilance of Canakinumab from the FDA Adverse Event Reporting System (FAERS)
PharmaceuticalsBackground: Canakinumab, a humanized anti-IL-1β monoclonal antibody, is known for its ability to suppress IL-1β-mediated inflammation. However, continuous monitoring of its safety remains essential.
Weidong Zhang +5 more
doaj +1 more source
Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2–18 Years, Vaccine Adverse Event Reporting System, United States, July 2005–June 2012 [PDF]
, 2014 Penina Haber +6 more
openalex +1 more source
Advanced Engineering Materials, EarlyView.This study explores the energy conversion in powder bed fusion of polymers using laser beam for polyamide 12 and polypropylene powders. It combines material and process data, using dimensionless parameters and numerical models, to enable the prediction of suitable printing parameters.
Christian Schlör +9 more
wiley +1 more source
Committed to Safety: Ten Case Studies on Reducing Harm to Patients [PDF]
, 2006 Presents case studies of healthcare organizations, clinical teams, and learning collaborations to illustrate successful innovations for improving patient safety nationwide.
David Blumenthal, Douglas McCarthy
core
Low‐Activation Compositionally Complex Alloys for Advanced Nuclear Applications—A Review
Advanced Engineering Materials, EarlyView.Low‐activation compositionally complex alloys (LACCAs) are advanced metallic materials primarily composed of low‐activation elements, offering advantages such as rapid compliance with operational standards and safe recyclability. This review highlights their potential for extreme high‐temperature irradiation environments as structural materials for ...
Yangfan Wang +8 more
wiley +1 more source
Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events [PDF]
, 2015 Mitsuhiro Nakamura +9 more
openalex +1 more source